MSB 3.21% $1.13 mesoblast limited

Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes, page-108

  1. 7,922 Posts.
    lightbulb Created with Sketch. 627
    It takes a long time for these financial whizz kids and analysts to wake up
    Today is a bit of good new stuff on top of old stuff which we have been discussing for 11 months
    With Thursday’s NEJM it will hopefully have the imprimatur of a credible source which may be the beginning of the tide turning for the shareprice
    For all us that have long believed in the science …we knew it would come but it has been a long time coming
    Last edited by stocksa: 15/11/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.